-
Featured
Study Seeks FDA-approved Therapy for IgG4-related Disease
Massachusetts General Hospital is conducting an NIH-funded clinical trial exploring elotuzumab as a treatment for IgG4-related disease.
-
Medical Grand Rounds: The Mass General Story of IgG4-related Disease
In a recent Medical Grand Rounds presentation, the Division of Rheumatology, Allergy, and Immunology at Massachusetts General Hospital presented on IgG4-related disease, reviewing the disease's early history at Mass General, its major clinical manifestations, ongoing clinical trials, and more.
-
Illness-related Uncertainty Correlates With Mental Health in Patients With Systemic Autoimmune Diseases
Zachary S. Wallace, MD, MSc, Daniel L. Hall, PhD, and colleagues found associations between illness-related uncertainty and psychologic health in patients with systemic autoimmune rheumatic diseases, and the measures varied according to type of disease.
-
Transforming Understanding of IGg4-Related Systemic Disease
A Massachusetts General Hospital rheumatologist is leading efforts to recognize and treat previously misdiagnosed and misunderstood IGg4-related systemic disease.
-
Treatment for IgG4-related Disease to Improve Within Five Years
Three drugs currently in clinical trials could lead to improvements in treatment for IgG4-related disease over the next three to five years.
-
First Classification Criteria Developed for IgG4–Related Disease
The American College of Rheumatology and the European League Against Rheumatism that includes Massachusetts General Hospital physicians have developed and validated classification criteria for IgG4–related disease in a large cohort of patients.
IgG4-related Disease Contributors
-
Cory A. Perugino, DO
Assistant in Medicine, Massachusetts General Hospital, Instructor in Medicine, Harvard Medical School
Recent Article
Medical Grand Rounds: The Mass General Story of IgG4-related Disease -
John H. Stone, MD, MPH
Director, Clinical Rheumatology, Massachusetts General Hospital, Edward A. Fox Chair in Medicine at Mass General
Recent Article
Medical Grand Rounds: The Mass General Story of IgG4-related Disease
-
Shiv Pillai, MD, PhD
Principal Investigator, Ragon Institute of MGH, MIT and Harvard, Associate Geneticist, Center for Cancer Research, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School
Recent Article
Study Seeks FDA-approved Therapy for IgG4-related Disease -
Zachary S. Wallace, MD, MSc
Co-Director, Rheumatology Vasculitis Program, Physician, Rheumatology Unit, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Mass General Program One of the Few in the World to Focus on Vasculitis Patients
Rheumatology, Allergy and Immunology
The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.